Michael Bertoldo thinks it is important for cancer survivors to live a life as normal as possible after cancer. For some people having the opportunity to have children is a big part of that normality. Michael trained as reproductive biologist at the University of Sydney where he completed his PhD on the role of egg quality in pregnancy loss. From there he undertook 3 years of post-doctoral research in France to develop ovarian tissue culture systems for fertility preservation. In 2014 he was recruited to the School of Women’s and Children’s Health at the University of NSW and was involved in studies to enhance assisted reproduction outcomes. In 2017 he accepted a joint position with UNSW and Jumpstart Fertility as a scientific advisor and to develop NAD therapies against reproductive ageing. Michael has received national and international awards for his research and was named a Churchill Fellow in 2018. In 2021 he became Medical Science Associate at Ferring Pharmaceuticals as a specialist in Reproductive Medicine and Maternal Health.